Understanding Value Stocks
A value stock is traditionally defined in terms of how investors in the marketplace are valuing that company's future growth prospects. Low P/E multiples are good base indicators that the company is undervalued and can most likely be labelled as a value stock.
The following stocks are considered to be notable value stocks in the healthcare sector:
- Organogenesis Hldgs ORGO - P/E: 5.78
- Maravai LifeSciences MRVI - P/E: 8.06
- Aadi Bioscience AADI - P/E: 2.7
- AcelRx Pharmaceuticals ACRX - P/E: 0.32
- Vir Biotechnology VIR - P/E: 3.62
Organogenesis Hldgs's earnings per share for Q3 sits at $0.04, whereas in Q2, they were at 0.09. Most recently, Maravai LifeSciences reported earnings per share at $0.37, whereas in Q2 earnings per share sat at $0.54. Most recently, Aadi Bioscience reported earnings per share at $-0.68, whereas in Q2 earnings per share sat at $-0.69. Most recently, AcelRx Pharmaceuticals reported earnings per share at $-0.94, whereas in Q2 earnings per share sat at $-1.2. Most recently, Vir Biotechnology reported earnings per share at $1.3, whereas in Q2 earnings per share sat at $-0.58.
The Significance: A value stock may need some time to rebound from its undervalued position. The risk of investing in a value stock is that this emergence may never materialize.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.